WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Syndax Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis PodlesakDirector2026-10-298,000$14.21
$113.71kSell
Dennis PodlesakDirector2026-10-298,000$11.81
$94.48kBuy
Michael A. MetzgerChief Executive Officer2026-07-0832,375$24.24
$784.77kSell
Michael A. MetzgerChief Executive Officer2026-07-0832,375$6.38
$206.55kBuy
Nicholas Aj BotwoodHead of RD CMO2026-06-1231,235$13.82
$431.67kBuy
Nicholas Aj BotwoodHead of RD CMO2026-06-1231,235$18.14
$566.60kSell
Nicholas Aj BotwoodHead of RD CMO2026-06-1122,515$13.82
$311.16kBuy
Nicholas Aj BotwoodHead of RD CMO2026-06-1134,280$18.00
$617.04kSell
Keith A. GoldanChief Financial Officer2026-06-011,177$18.99
$22.35kSell
Michael A. MetzgerChief Executive Officer2026-06-016,847$18.99
$130.02kSell

1 of 2

SNDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNDX insiders and whales buy or sell their stock.

SNDX Shareholders

What type of owners hold Syndax Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mpm Bioventures IV Qp LP2.41%2,168,691$20.71MInsider
Luke Evnin2.41%2,168,691$20.71MInsider
Domain Partners VI LP1.94%1,743,854$16.65MInsider
Domain Partners VIII LP0.85%761,062$7.27MInsider
Ivor Royston0.69%625,545$5.97MInsider
Michael A. Metzger0.54%484,843$4.63MInsider
Dennis Podlesak0.27%239,763$2.29MInsider
Keith A. Goldan0.15%139,252$1.33MInsider
Keith Katkin0.14%124,000$1.18MInsider
Jennifer Jarrett0.13%114,000$1.09MInsider

1 of 3

SNDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNDX0.12%10.32%Net SellingNet Buying
OBX0.00%0.05%
IMTX0.07%16.35%Net BuyingNet Buying
ALMS0.09%28.51%Net BuyingNet Buying
LXRX0.03%99.97%Net BuyingNet Buying
View Top Biotech Stocks

Syndax Pharmaceuticals Stock Ownership FAQ

Who owns Syndax Pharmaceuticals?

Syndax Pharmaceuticals (NASDAQ: SNDX) is owned by 0.12% institutional shareholders, 10.32% Syndax Pharmaceuticals insiders, and 89.56% retail investors. Mpm Bioventures IV Qp LP is the largest individual Syndax Pharmaceuticals shareholder, owning 2.17M shares representing 2.41% of the company. Mpm Bioventures IV Qp LP's Syndax Pharmaceuticals shares are currently valued at $20.58M.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.